Alzheimer's & Dementia

Alzheimer’s disease is an irreversible, progressive brain disorder that slowly destroys memory and thinking skills. Alzheimer’s is the most common cause of dementia among older adults. Dementia is the loss of cognitive functioning—thinking, remembering, and reasoning—and behavioral abilities to such an extent that it interferes with a person’s daily life and activities.

Alzheimer’s Disease | Definition, Causes, Diagnosis & Treatment

Alzheimer’s Disease (AD) is the most common form of dementia worldwide (60-70% of all dementia cases) and is a progressive neurodegenerative disorder.

Bright Light Therapy and Dementia

Mixed Dementia Prevention and Treatment

What is Mixed Dementia?

Does Type 2 Diabetes Increase the Risk of Alzheimer’s Disease?

Alzheimer's and Veganism

Pollution and Alzheimer's

Alzheimer's Disease Epidemiology

Does Herpesvirus Cause Alzheimer's?

Coconut Oil and Dementia

Does Depression and Anxiety Increase the Risk of Dementia?

Is Alzheimer's Disease Transmissible?

See more featured articles »

Alzheimer's Disease Diagnosis

Antibody Research and Alzheimer’s Disease

Antidepressants and Dementia: Is There a Link?

Migraines and Dementia

Childhood Dementia Causes

Gender and Alzheimer’s Risk

Do Antioxidants Benefit Patients with Alzheimer’s and Parkinson’s?

AAM - Air pollution and Alzheimer's

Stem Cell Therapy for Alzheimer's

Dementia with Lewy Bodies

Parkinson's Compared to Dementia with Lewy Bodies (DLB)

Dementia Treatment

Differences Between Alzheimer's and Dementia

Diet and Alzheimer's Disease

Does Type 2 Diabetes Increase the Risk of Alzheimer’s Disease?

AAM - The Search for a Cure to Alzheimer's

Dancing Through Dementia: How Movement Aids Memory and Mood

Omega-3 and Alzheimer’s Disease

What are Amyloid Plaques?

Dementia Symptoms

Dementia Diagnosis

Integrated PET/MR for Alzheimer’s Disease

Dementia Prevention

Alzheimer’s tangles and plaques: what’s the difference?

Alzheimer's Disease Symptoms

Mythbusting: Misconceptions in Dementia

AAM - Genetics of Alzheimer's

Childhood Dementia Signs and Symptoms

Aromatherapy for Dementia

Types of Alzheimer's Disease

Can Statins Protect Against Alzheimer’s Disease?

Amyloid Cascade Hypothesis

Alzheimer's Disease Prevention

Can Happiness Protect You from Dementia?

Alzheimer’s Disease and Calcium Supplements

Transcutaneous Electrical Nerve Stimulation for Dementia

Alzheimer's Disease Treatments

Alzheimer's Disease and Sleep Disruption

Alzheimer's Disease Questions

Mixed Dementia Symptoms and Diagnosis

Alzheimer's Disease and the Microbiome

Biomarkers for Alzheimer's Disease

What Causes Dementia?

Alzheimer’s Disease and Gingko Biloba

Stress and Alzheimer's Disease

Designing Dementia-Friendly Environments

What is Dementia?

Inflammation and Alzheimer's Disease

Alzheimer's Disease Causes

Latest Alzheimer's & Dementia News and Research

Errors in EPG5 gene implicated in rare infant condition and adult neurodegenerative diseases

Errors in a gene known to cause a serious neurodevelopmental condition in infants are also linked to the development of Parkinson's disease in adolescence and adulthood, according to new research.

9 Oct 2025

Obesity-linked fat vesicles accelerate amyloid aggregation in Alzheimer’s disease

Researchers discuss the role of extracellular vesicles as a potential link between obesity and Alzheimer’s disease.

9 Oct 2025

University Of California researchers, patients wary of Trump cuts even as some dollars flow again

In August, an 80-year-old woman walked into the emergency room at Ronald Reagan UCLA Medical Center. She was lucid but experiencing a stroke.

9 Oct 2025

Fermented soy boosts memory in older adults

Findings from a study reveal that fermented soy may boost memory function in older adults, especially postmenopausal women, offering dietary cognitive support.

9 Oct 2025

Research uncovers ASPL's critical role in stress granule life cycle

Stress granules are droplet-like protein hubs that temporarily shield fragile RNA from cellular stresses such as toxins. VCP is a protein essential for breaking up stress granules and has been linked to neurodegenerative diseases.

9 Oct 2025

Brainstem damage found to be behind long-lasting effects of severe Covid-19

Damage to the brainstem - the brain's 'control center' - is behind long-lasting physical and psychiatric effects of severe Covid-19 infection, a study suggests.

8 Oct 2025

Largest study of African American brain tissue reveals key Alzheimer gene activity

The prevalence of Alzheimer disease (AD) is approximately two times higher in African Americans (AA) compared to White/European-ancestry (EA) individuals living in the U.S.

8 Oct 2025

This geriatrics training program escaped the Ax. for now.

In St. Louis, a team of students aboard a well-equipped van visits senior centers, a nursing home, a church, and other sites, learning to conduct comprehensive, hourlong geriatric assessments.

8 Oct 2025

Huawei smartwatch nearly matches gold-standard sleep test

A study reveals the HUAWEI WATCH GT2 smartwatch accurately tracks sleep stages, yet it falls short in diagnosing sleep disorders compared to PSG.

7 Oct 2025

Nanotechnology breakthrough reverses Alzheimer’s disease in mice

A research team co-led by the Institute for Bioengineering of Catalonia (IBEC) and West China Hospital Sichuan University (WCHSU), working with partners in the UK, has demonstrated a nanotechnology strategy that reverses Alzheimer's disease in mice.

6 Oct 2025

Advancing precision medicine to transform obesity prevention and treatment

A new report led by researchers at Pennington Biomedical Research Center underscores the growing potential of precision medicine to transform how obesity is prevented, diagnosed and treated, while also illuminating key gaps and challenges that must be addressed.

6 Oct 2025

Investigating cannabidiol's role in combating Alzheimer's-related neuroinflammation

Neuroinflammation damages neurons and can contribute to diseases like Alzheimer's. Cannabidiol (CBD) has anti-inflammatory properties, which suggests that it could combat neuroinflammation in Alzheimer's.

6 Oct 2025

TBI-associated dementia risk emphasizes need for targeted fall prevention programs

Traumatic brain injuries (TBI) in older adults are associated with new cases of dementia, use of home care services, and admission to long-term care, according to new research published in CMAJ (Canadian Medical Association Journal)

6 Oct 2025

Study suggests spatial memory decline may be preventable and not universal

In the realm of memories, "where" holds special importance. Where did I leave my keys? Where did I eat dinner last night? Where did I first meet that friend? Recalling locations is necessary for daily life, yet spatial memory - which keeps track of "where" - is one of the first cognitive abilities to fade in old age. And deficits earlier in life can be a telltale sign of dementia.

3 Oct 2025

Cell messengers signal amyloid plaque buildup in obese individuals

Obesity has long been acknowledged as a risk factor for a wide range of diseases, but a more precise link between obesity and Alzheimer's disease has remained a mystery – until now.

3 Oct 2025

Study links high neuroinflammation in young people with Down Syndrome to Alzheimer's risk

Down syndrome is associated with accelerated aging. It is estimated that up to 90% of individuals with the condition develop Alzheimer's disease before the age of 70. A study by researchers at the University of São Paulo (USP) in Brazil identified high levels of neuroinflammation in young individuals with Down syndrome, an additional factor explaining the high prevalence of Alzheimer's disease in older people with the condition. The discovery paves the way for strategies to prevent and monitor the disease.

3 Oct 2025

Scientists discover new protein family regulating motility and DNA uptake

Bioengineers at the University of California San Diego have developed a powerful new technology that can map the entire network of RNA-protein interactions inside human cells - an achievement that could offer new strategies for treating diseases ranging from cancer to Alzheimer's.

3 Oct 2025

Thermo Fisher Scientific expands neurodegeneration research capabilities with launch of Olink® Target 48 Neurodegeneration panel

Thermo Fisher Scientific Inc., the world leader in serving science, today announced the launch of the Olink® Target 48 Neurodegeneration panel, a high-performance, targeted proteomics immunoassay panel developed to accelerate discoveries in neurodegenerative disease research.

From Olink®- Part of Thermo Fisher Scientific 3 Oct 2025